Novo Nordisk (NVO) said Monday it has agreed to buy Benchmark Genetics, a Norwegian fish genetics company, from Benchmark Holdings for up to 260 million British pounds ($326.5 million).
Benchmark Genetics specializes in salmonid genetics, providing eggs and services to farmers in Norway, Iceland, the Faroe Islands, Chile, and other regions, Novo Nordisk said.
Price: 104.49, Change: -0.57, Percent Change: -0.54
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.